Deep Track Capital, LP Autolus Therapeutics PLC Transaction History
Deep Track Capital, LP
- $2.82 Billion
- Q2 2025
A detailed history of Deep Track Capital, LP transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Deep Track Capital, LP holds 16,852,147 shares of AUTL stock, worth $26.6 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
16,852,147
Previous 17,849,482
5.59%
Holding current value
$26.6 Million
Previous $27.7 Million
38.88%
% of portfolio
1.36%
Previous 0.97%
Shares
8 transactions
Others Institutions Holding AUTL
# of Institutions
100Shares Held
165MCall Options Held
0Put Options Held
39.3K-
Wellington Management Group LLP Boston, MA27.1MShares$42.9 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$32.4 Million0.22% of portfolio
-
Mak Capital One LLC New York, NY17MShares$26.8 Million5.54% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$26.3 Million98.24% of portfolio
-
Armistice Capital, LLC New York, NY12MShares$19 Million0.48% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $144M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...